|
|
Clinical Genetics and Metabolism
Research Funding
(listed alphabetically by Principal Investigator)
Center for Research in Mental Retardation (supports tissue culture, molecular biology, enzyme and molecular diagnostic, mass spectrometry, animal behavior, human subjects recruitment and evaluation and developmental neuropsychology core facilities)
Program Director: Stephen I. Goodman, MD
Core Director of Tissue Culture: Stephen I. Goodman, MD
Core Director of Molecular Biology: Jan P. Kraus, PhD
Core Directors of Enzyme and Molecular Diagnosis: Frank E. Frerman, PhD, and Elaine B. Spector, PhD
Core Director of Chemistry/Mass Spectrometry: Paul V. Fennessey, PhD
Core Director of Animal Housing and Assessment: Kenneth N. Maclean, PhD
Core Director of Human Subjects Recruitment and Evaluation: Randal Ross, MD
Source: National Institutes of Health, National Institute of Child Health and Human Development - HD04024
Amount: $4,976,931
Term: 2003-2008
Genetic Biochemical Disorders in Mental Retardation
Program Director and Principal Investigator: Stephen I. Goodman, MD
Source: National Institutes of Health, National Institute of Child Health and Human Development - HD08315
Amount: $6,113,976
Term: 2000-2005
- The Biochemical and Molecular Basis of ETF-QO Deficiency
Principal Investigator: Frank E. Frerman, PhD
- The Biochemical and Molecular Bases of Glutaric and D-2-Hydroxyglutaric Acidemia
Principal Investigator: Stephen I. Goodman, MD
- The Molecular Biology of ATMI, a Putative Mitochondrial Iron Transporter
Principal Investigator: David M. Koeller, MD
- The Molecular Basis of CBC Disorders in Human Disease
Principal Investigator: Jan P. Kraus, PhD
- The Molecular Basis of Propionic Acidemia
Principal Investigator: Jan P. Kraus, PhD
Denver Autoimmunity Center of Excellence
Principal Investigator: Michael Holers, MD
Basic Project III: Genetic Analysis of Autoimmune Polyendocrine Syndrome-II
Principal Investigator: Richard A. Spritz, MD
Co-Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health, National Institute of Allergy and Infectious Diseases - U19-AI46374
Amount: $150,000/yr
Term: 2003-2008
Homocysteine and Thrombosis
Principal Investigator: Jan P. Kraus, PhD
Source: National Heart, Lung and Blood Institute - HL65217
Amount: $566,250
Term: 2000-2005
Mouse Models of CBS Deficient Homocystinuria
Principal Investigator: Jan P. Kraus, PhD
Source: Jerome LeJeune Foundation
Amount: $50,000
Term: 2005-2007
Genetics, Neurobiology and Cognition in Down Syndrome
Principal Investigator: Kenneth N. Maclean, PhD
Source: National Institutes of Health, National Institute of Child Health and Human Development - HD45224
Amount: $1,260,305
Term: 2003-2007
Attentional Dysfunction in Fragile X Syndrome
Principal Investigator: Kenneth N. Maclean, PhD
Source: National Institutes of Health, National Institute of Child Health and Human Development - HD047029
Amount: $1,049,609
Term: 2003-2008
Rare Liver Disease Network
Principal Investigator: Ronald J. Sokol, MD
Co-Investigator: Johan Van Hove, MD, PhD
Source: National Institutes of Health - U54 RR019455
Amount: $4,700,000
Term: 2004-2009
Genetic Studies of Human Pigmentation Disorders
Principal Investigator: Richard A. Spritz, MD
Source: National Institutes of Health, National Institute of Arthritis, Musculoskeletal and Skin Diseases - AR039892
Amount: $465,433/yr
Term: 2001-2006
Mapping of Vitiligo Susceptibility Genes
Principal Investigator: Richard A. Spritz, MD
Co-Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health, National Institute of Arthritis, Musculoskeletal and Skin Diseases - 5R01AR045584-06
Amount: $547,668/yr
Term: 2004-2009
Gene Discovery for Craniofacial Disorders
Principal Investigator: Richard A. Spritz, MD
Source: National Institutes of Health, National Institute of Dental and Craniofacial Research - DE015191
Amount: $375,154/yr
Term: 2003-2007
Missing Mutations in Oculocutaneous and Ocular Albinism
Principal Investigator: Richard A. Spritz, MD
Source: National Institutes of Health, National Eye Institute - EY015626
Amount: $285,409/yr
Term: 2004-2007
Development of Center of Excellence for Lysosomal Storage Disease
Principal Investigators: Matthew R. G. Taylor, MD, and Janet A. Thomas, MD
Source: Genzyme Therapeutics
Amount: $68,000/yr
Term: 2003-2006
Iduronate-2-Sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPSII): TKT - Clinical Protocol No. TKT024Ext
Principal Investigator: Janet A. Thomas, MD
Source: Transkaryotic Therapies, Inc.
Amount: $51,7620
Term: 2005-2007
Natural History of Recombinant 8 Syndrome
Principal Investigator: Chun-Hui (Anne) Tsai, MD, MSc
Source: Mountain States Genetic Network
Amount: $30,000
Term: 2005-2006
2003-2004
Aged Forebrain Cholinergic Neurons: Estrogen and NGF
Co-Investigator: Linda S. Crnic, PhD
Source: National Institutes of Health, National Institute of Aging - AG12122
Amount: $1,213,670/yr
Term: 2000-2003
Program Project Grant - Somatic Cell Genetic Studies of Down Syndrome
Principal Investigator: David Patterson, PhD
Source: National Institutes of Health, National Institute of Child Health and Human Development - HD17449
Term: 1997-2003
- Behavioral Assessment Core
Principal Investigator: Linda S. Crnic, PhD
Amount: $552,750
- Project 7: Behavioral Analysis of a Mouse Model of Down Syndrome
Principal Investigator: Linda S. Crnic, PhD
Amount: $700,827
Video Analysis System for Home Cage Behavior
Co-Investigator: Linda S. Crnic, PhD
Source: National Institutes of Health, National Institute of Mental Health - MH58964
Amount: $53,448
Term: 2000-2003
Treatment of a Mouse Model of Fragile X Syndrome with MPEP
Principal Investigator: Linda S. Crnic, PhD
Source: Fragile X Association
Amount: $49,000
Term: 2003-2004
Glutaryl-CoA Dehydrogenase and Neurologic Disease
Principal Investigator: Frank E. Frerman, PhD
Source: National Institute of Neurological Disorders and Stroke - NS39339
Amount: $1,064,286
Term: 1999-2003
Genetic Biochemical Disorders in Mental Retardation
Program Director and Principal Investigator: Stephen I. Goodman, MD
Source: National Institutes of Health, National Institute of Child Health and Human Development - HD08315
Amount: $6,113,976
Term: 2000-2005
- The Biochemical and Molecular Basis of ETF-QO Deficiency
Principal Investigator: Frank E. Frerman, PhD
- The Biochemical and Molecular Bases of Glutaric and D-2-Hydroxyglutaric Acidemia
Principal Investigator: Stephen I. Goodman, MD
- The Molecular Biology of ATMI, a Putative Mitochondrial Iron Transporter
Principal Investigator: David M. Koeller, MD
- The Molecular Basis of CBC Disorders in Human Disease
Principal Investigator: Jan P. Kraus, PhD
- The Molecular Basis of Propionic Acidemia
Principal Investigator: Jan P. Kraus, PhD
Center for Research in Mental Retardation (supports tissue culture, molecular biology, enzyme and molecular diagnostic, mass spectrometry, animal behavior, human subjects recruitment and evaluation and developmental neuropsychology core facilities)
Program Director: Stephen I. Goodman, MD
Core Director of Tissue Culture: Stephen I. Goodman, MD
Core Director of Molecular Biology: Jan P. Kraus, PhD
Core Directors of Enzyme and Molecular Diagnosis: Frank E. Frerman, PhD, and Elaine B. Spector, PhD
Core Director of Chemistry/Mass Spectrometry: Paul V. Fennessey, PhD
Core Director of Animal Housing and Assessment: Stephen I. Goodman, MD
Core Director of Human Subjects Recruitment and Evaluation: Randal Ross, MD
Source: National Institutes of Health, National Institute of Child Health and Human Development - HD04024
Amount: $4,976,931
Term: 2003-2008
Homocysteine and Thrombosis
Principal Investigator: Jan P. Kraus, PhD
Source: National Heart, Lung and Blood Institute - HL65217
Amount: $566,250
Term: 2000-2005
Genetics, Neurobiology and Cognition in Down Syndrome
Principal Investigator: Kenneth N. Maclean, PhD
Source: National Institutes of Health, National Institute of Child Health and Human Development - HD45224
Amount: $1,260,305
Term: 2003-2007
Attentional Dysfunction in Fragile X Syndrome
Principal Investigator: Kenneth N. Maclean, PhD
Source: National Institutes of Health, National Institute of Child Health and Human Development - HD047029
Amount: $1,049,609
Term: 2003-2008
Treatment of Cystathionine Beta Synthase Knockout Mice with Cystatyionine: A New Essential Amino Acid?
Principal Investigator: Kenneth N. Maclean, PhD
Source: The Children's Hospital Research Institute #6703
Amount: $30,000
Term: 2002-2004
Mapping of Vitiligo Susceptibility Genes
Principal Investigator: Richard A. Spritz, MD
Co-Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health, National Institute of Arthritis, Musculoskeletal and Skin Diseases - AR045584
Amount: $544,954/yr
Term: 2004-2009
Genetic Studies of Human Pigmentation Disorders
Principal Investigator: Richard A. Spritz, MD
Source: National Institutes of Health, National Institute of Arthritis, Musculoskeletal and Skin Diseases - AR039892
Amount: $465,433/yr
Term: 2001-2006
Gene Discovery for Craniofacial Disorders
Principal Investigator: Richard A. Spritz, MD
Source: National Institutes of Health, National Institute of Dental and Craniofacial Research - DE015191
Amount: $375,154/yr
Term: 2003-2007
Missing Mutations in Oculocutaneous and Ocular Albinism
Principal Investigator: Richard A. Spritz, MD
Source: National Institutes of Health, National Eye Institute - EY015626
Amount: $285,409/yr
Term: 2004-2007
Denver Autoimmunity Center of Excellence
Principal Investigator: Michael Holers, MD
Basic Project III: Genetic Analysis of Autoimmune Polyendocrine Syndrome-II
Principal Investigator: Richard A. Spritz, MD
Co-Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health, National Institute of Allergy and Infectious Diseases - U19-AI46374
Amount: $150,000/yr
Term: 2003-2008
Development of Center of Excellence for Lysosomal Storage Disease
Principal Investigators: Matthew R. G. Taylor, MD, and Janet A. Thomas, MD
Source: Genzyme Therapeutics
Amount: $68,000/yr
Term: 2003-2006
Clinical Experience with 3360 C-3360 in the Dietary Management of Amino Acid Inborn Errors of Metabolism
Principal Investigator: Janet A. Thomas, MD
Source: Mead Johnson and Company
Amount: $2,850 per patient plus $2,000
Term: 2002-2003
The Use of the MiniMed Continuous Glucose Monitoring System in the Management of Glycogen Storage Disease, Type IA
Principal Investigator: Janet A. Thomas, MD
Source: MiniMed, Inc.
Amount: Supplying CGMS, sensors and software
Term: 2001-2003
Coenzyme A Metabolism in the Pathophysiology of Fatty Acid Oxidation Disorders
Principle Investigator: Johan L. Van Hove, MD, PhD
Co-Investigators: Jaak Jaeken, MD, PhD, and Hubert Carchon, PhD
Source: Onderzoekstoelage KULeuven (University Research Grant), Belgium
Amount: $182,000
Term: 2000-2003
2001-2002
Age-Related Changes in Ts65Dn Mouse Forebrain and Learning
Principal Investigator: Linda S. Crnic, PhD
Fellow: Lynn Hyde, PhD
Source: National Institutes of Health, National Institute of Aging - 5 F32 AG05866-0151
Amount: $60,000
Term: 1999-2001
Aged Forebrain Cholinergic Neurons: Estrogen and NGF
Co-Investigator: Linda S. Crnic, PhD
Source: National Institutes of Health, National Institute of Aging - AG12122
Amount: $1,213,670/yr
Term: 2000-2003
Center for Research in Mental Retardation (supports tissue culture, animal behavior, molecular biology and developmental neuropsychology core facilities of the center)
Program Director: Linda S. Crnic, PhD
Core Directors of Cell Biology: Stephen I. Goodman, MD, and Jan P. Kraus, PhD
Core Directors of Enzyme and Molecular Diagnosis: Frank E. Frerman, PhD, and Elaine Spector, PhD
Principal Investigator of Chemistry/Mass Spectrometry Core: Paul V. Fennessey, PhD
Principal Investigator of Animal Housing and Assessment Core: Linda Crnic, PhD
Source: National Institutes of Health, National Institute of Child Health and Human Development - HD04024
Amount: $3,819,647
Term: 1998-2003
Program Project Grant - Somatic Cell Genetic Studies of Down Syndrome
Principal Investigator: David Patterson, PhD
Source: National Institutes of Health, National Institute of Child Health and Human Development - HD17449
Term: 1997-2003
- Behavioral Assessment Core
Principal Investigator: Linda S. Crnic, PhD
Amount: $552,750
- Project 7: Behavioral Analysis of a Mouse Model of Down Syndrome
Principal Investigator: Linda S. Crnic, PhD
Amount: $700,827
Video Analysis System for Home Cage Behavior
Co-Investigator: Linda S. Crnic, PhD
Source: National Institutes of Health, National Institute of Mental Health - MH58964
Amount: $53,448
Term: 2000-2003
Glutaryl-CoA Dehydrogenase and Neurologic Disease
Principal Investigator: Frank E. Frerman, PhD
Source: National Institute of Neurological Disorders and Stroke - NS39339
Amount: $254,518/yr
Term: 1999-2003
Genetic Biochemical Disorders in Mental Retardation
Program Director and Principal Investigator: Stephen I. Goodman, MD
Source: National Institutes of Health, National Institute of Child Health and Human Development - HD08315
Amount: $6,113,976
Term: 2000-2005
- Mass Spectrometry Core
Principal Investigator: Paul V. Fennessey, PhD
- The Biochemical and Molecular Basis of ETF-QO Deficiency
Principal Investigator: Frank E. Frerman, PhD
- The Biochemical and Molecular Bases of Glutaric and D-2-Hydroxyglutaric Acidemia
Principal Investigator: Stephen I. Goodman, MD
- The Molecular Biology of ATMI, a Putative Mitochondrial Iron Transporter
Principal Investigator: David M. Koeller, MD
- The Molecular Basis of CBC Disorders in Human Disease
Principal Investigator: Jan P. Kraus, PhD
- The Molecular Basis of Propionic Acidemia
Principal Investigator: Jan P. Kraus, PhD
Denver Autoimmunity Center of Excellence
Principal Investigator: Brian L. Kotzin, MD
Co-Investigator: Pamela R. Fain, PhD
Basic Project III: Genetic Analysis of Autoimmune Polyendocrine Syndrome-II
Principal Investigator: Richard A. Spritz, MD
Source: National Institutes of Health, National Institute of Allergy and Infectious Diseases - U19-AI46374
Amount: $796,370
Term: 1999-2004
Homocysteine and Thrombosis
Principal Investigator: Jan P. Kraus, PhD
Source: National Heart, Lung and Blood Institute - HL65217
Amount: $75,000/yr
Term: 2000-2005
Genetic Studies of Human Pigmentation Disorders
Principal Investigator: Richard A. Spritz, MD
Source: National Institutes of Health, National Institute of Arthritis, Musculoskeletal and Skin Diseases - AR39892
Amount: $3,313,328
Term: 1996-2005
Genetic Studies of Margarita Island Ectodermal Dysplasia
Principal Investigator: Richard A. Spritz, MD
Source: National Foundation for Ectodermal Dysplasias
Amount: $45,000
Term: 1999-2001
Genetic Studies of Margarita Island Ectodermal Dysplasia
Principal Investigator: Richard A. Spritz, MD
Source: National Institutes of Health, National Institute of Dental and Craniofacial Research - DE13571
Amount: $209,275
Term: 1999-2002
Mapping of Vitiligo Susceptibility Genes
Principal Investigator: Richard A. Spritz, MD
Co-Investigator: Pamela R. Fain, PhD
Source: National Institutes of Health, National Institute of Arthritis, Musculoskeletal and Skin Diseases - AR45584
Amount: $1,436,489
Term: 1999-2003
Chromosome 22q Deletion Testing: Investigation of Clinical Predictive Factors
Principal Investigator: Janet A. Thomas, MD
Co-Investigator: Matthew R. G. Taylor, MD
Source: Mountain States Regional Genetics Services Network, Research and Development - 00-182
Amount: $1,490
Term: 2001
Clinical Experience with 3360 C-3360 L in the Dietary Management of Amino Acid Inborn Errors of Metabolism
Principal Investigator: Janet A. Thomas, MD
Source: Mead Johnson and Company
Amount: $2,850 per patient plus $2,000
Term:2002-2003
Does Twinning Influence the Reliability of the Thyroid NBN Screening Test?
Principal Investigator: Janet A. Thomas, MD
Source: Pediatric General Clinical Research Center
Biochemical and Clinical Investigations of Inborn Errors of Metabolism
Principal Investigator: Janet A. Thomas, MD
Source: Mead Johnson and Company
Investigation of Hyphenylalaninemia and Phenylketonuria
Principal Investigator: Janet A. Thomas, MD
Epidemiological Study of the Natural History of Fabry Disease (AGAL 014-01)
Principal Investigator: Janet A. Thomas, MD
Source: Genzyme Corporation - 01-582
Amount: $3,528
Term: 2001
Epidemiologic Study of the Natural History of Infantile Pompe Disease
Principal Investigator: Janet A. Thomas, MD
Source: Genzyme Corporation
Amount: $1,800
Term: 2002
Fabry International Research Exchange (FIRE). A Registry of Fabry Disease: A Multicenter, Longitudinal, Observational Study
Principal Investigator: Janet A. Thomas, MD
Source: Transkaryotic Therapies, Inc. - 01-846
Amount: $3,500 per patient per year
Term: 2001
Investigation of Growth Hormone Deficiency in Patients with Organic Acidemia and Short Stature
Principal Investigator: Janet A. Thomas, MD
Source: Eli Lilly Company - 00-1121
Amount: $20,000
Term: 2001
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Recombinant Human A-Galactosidase A (R-HAGAL) on Progression of Renal Disease and Significant Clinical Events in Patients with Fabry Disease (AGAL-008)
Principal Investigator: Janet A. Thomas, MD
Co-Investigator: Matthew R. G. Taylor, MD
Source: Genzyme Corporation - 01-606
Amount: $104,327 per patient for two years
Term: 2001
The Use of the MiniMed Continuous Glucose Monitoring System in the Management of Glycogen Storage Disease, Type IA
Principal Investigator: Janet A. Thomas, MD
Source: MiniMed, Inc.
Amount: Supplying CGMS, sensors and software
Term: 2001-2003
A Prospective, Multinational, Multicenter, Clinical Trial of the Safety and Efficacy of Recombinant Human Acid alpha-Glucosidase (Rhgaa) in Cross-Reacting Immunologic Material Positive (Crim(+)) Patients with Classical Infantile Pompe Disease
Principal Investigator: Chun-Hui (Anne) Tsai, MD
Co-Investigator: Janet A. Thomas, MD
Source: Genzyme Corporation - 01-585
Amount: $42,572 per patient per year
Term: 2001
1999-2000
Reference Guide for Hyperphenylalaninemia
Principal Investigators: Laurie Bernstein, MS, RD, FADA, and Cindy Freehauf, RN, MS
Source: Scientific Hospital Supplies, Inc.
Amount: $5,000
Term: September 1998-September 1999
Growth, Tolerance, Plasma Amino Acids and Plasma Biochemistries of Infants and Toddlers with Urea Cycle Disorders
Principal Investigator: Laurie Bernstein, MS, RD, FADA
Source: Ross Laboratories Collaborative Study
Amount: $900
Term: June 1999-June 2000
Diet Intervention for the Late-Treated Adult with PKU
Principal Investigator: Laurie Bernstein, MS, RD, FADA
Source: Ross Laboratories
Amount: $1,500
Term: 1998-1999
Center for Research in Mental Retardation
Program Director: Stephen I. Goodman, MD
Core Directors: Frank E. Frerman, PhD, and Jan Kraus, PhD
Principal Investigator: Analytical Core: Paul V. Fennessey, PhD
Principal Investigator: Animal Housing and Assessment Core: Linda Crnic, PhD
Source: National Institute of Child Health and Human Development
Amount: $624,654/yr
Term: August 1998-July 2003
Center Grant for Research in Mental Retardation (supports tissue culture, animal behavior, molecular biology and developmental neuropsychology core facilities of the center)
Program Director: Stephen I. Goodman, MD
Source: National Institute of Child Health and Human Development
Amount: $3,819,647
Term: August 1998-July 2003
Genetic Biochemical Disorders in Mental Retardation
Program Director: Stephen I. Goodman, MD
Source: National Institute of Child Health and Human Development
Amount: $764,824/yr
Term: May 2000-April 2005
- Biochemical and Molecular Bases of Glutaric and D-2-Hydroxyglutaric Acidemia
Principal Investigator: Stephen I. Goodman, MD
- Molecular Biology of ATMI, A Putative Mitochondrial Iron Transporter
Principal Investigator: David M. Koeller, MD
- Biochemical and Molecular Basis of ETF-QO Deficiency
Principal Investigator: Frank E. Frerman, PhD
- The Molecular Basis of CBC Disorders in Human Disease
Principal Investigator: Jan P. Kraus, PhD
- The Molecular Basis of Propionic Acidemia
Principal Investigator: Jan P. Kraus, PhD
Program Project Grant - Somatic Cell Genetic Studies of Down Syndrome: Behavioral Assessment Core
Principal Investigator: Linda S. Crnic, PhD
Source: National Institute of Child Health and Human Development
Amount: $552,750
Term: January 1997-December 2002
Program Project Grant - Somatic Cell Genetic Studies of Down Syndrome: Behavioral Characterization of a Mouse Model of Down Syndrome
Principal Investigator: Linda S. Crnic, PhD
Source: National Institute of Child Health and Human Development
Amount: $700,827
Term: January 1997-December 2002
Brain Effects of Interferon-Alpha
Principal Investigator: Linda S. Crnic, PhD
Source: National Institute of Mental Health
Amount: $326,319
Term: July 1996-June 2000
Aged Forebrain Cholinergic Neurons: Estrogen and NGF
Co-Investigator: Linda S. Crnic, MD
Source: National Institute of Aging
Amount: $1,213,670
Term: August 2000-July 2005
Digital Video Analysis System for Home Cage Behavior
Co-Investigator: Linda S. Crnic, PhD
Source: National Institute of Mental Health
Amount: $53,448
Term: August 2000- July 2003
Development of Maladaptive Behavior
Co-Investigator, Co-Director and Acting Director: Linda S. Crnic, PhD
Source: National Institute of Mental Health
Amount: $1,051,991
Term: July 1996-June 2000
Training in Human Medical Genetics
Program Faculty: Linda S. Crnic, PhD
Source: National Institute of Child Health and Human Development
Amount: $105,842
Term: June 1996-July 2001
Glutaryl-CoA Dehydrogenase and Neurologic Disease
Principal Investigator: Frank E. Frerman, PhD
Source: National Institute of Neurological Disorders and Stroke
Amount: $254,518/yr
Term: December 1999 -November 2003
Research in Pediatric Diseases
Principal Investigator: Frank E. Frerman, PhD
Source: The Children's Hospital Research Institute
Amount: $50,000/yr
Term: November 1999 -October 2000
Characterization of a Mitochondrial Iron Transport
Principal Investigator: David M. Koeller, MD
Source: The Children's Hospital Research Institute
Amount: $10,000/yr
Term: August 1998-July 1999
Denver Autoimmunity Center of Excellence
Principal Investigator: Brian L. Kotzin, MD
Basic Project III: Genetic Analysis of Autoimmune Polyendocrine Syndrome-II
Principal Investigator: Richard A. Spritz, MD
Source: National Institutes of Health, National Institute of Allergy and Infectious Diseases - U19-AI46374
Amount: $796,370
Term: August 1999-July 2004
Homocysteine and Thrombosis
Principal Investigator: Jan P. Kraus, PhD
Source: National Heart, Lung and Blood Institute
Amount: $75,000/yr
Term: September 2000-August 2005
Mental Retardation Research Center Core Grant
Principal Investigator of Chemistry/Mass Spectrometry Core: Paul V. Fennessey, PhD
Source: National Institutes of Health
Amount: $4,099,309
Term: May 2000-April 2005
Genetic Studies of Human Pigmentation Disorders
Principal Investigator: Richard A. Spritz, MD
Source: National Institutes of Health, National Institute of Arthritis, Musculoskeletal and Skin Diseases - AR39892
Amount: $1,374,774
Term: June 1996-May 2001
Mapping of Vitiligo Susceptibility Genes
Principal Investigator: Richard A. Spritz, MD
Source: National Institutes of Health, National Institute of Arthritis, Musculoskeletal and Skin Diseases - AR45584
Amount: $1,436,489
Term: September 1999-August 2003
Gene Mapping of Ectodermal Dysplasias
Principal Investigator: Richard A. Spritz, MD
Source: March of Dimes Birth Defects Foundation - #1-FY98-0427
Amount: $108,036
Term: June 1998-May 2000
Genetic Studies of Margarita Island Ectodermal Dysplasia
Principal Investigator: Richard A. Spritz, MD
Source: National Foundation for Ectodermal Dysplasias
Amount: $45,000
Term: July 1999-June 2001
Genetic Studies of Margarita Island Ectodermal Dysplasia
Principal Investigator: Richard A. Spritz, MD
Source: National Institutes of Health, National Institute of Dental and Craniofacial Research - DE13571
Amount: $209,275
Term: December 1999-November 2002
A Genechip Instrument System for Gene Mapping Core Facility
Principal Investigator: Richard A. Spritz, MD
Source: National Institutes of Health, National Center for Research Resources
Amount: $175,000
Term: April 1999-March 2000
|
|
